Compliance Packaging Pharmaceutical Seed-To-Sale 
Cannabis Law Report
AUGUST 19, 2019
19 August 2019. Authors – Carolyn E. Pepper and Jess Parry. Recently, three British MPs went to Canada on a fact-finding cross-party trip to consider the effects of a more relaxed regulatory environment in respect of cannabis. What substances are at issue? Cannabinoids are the chemical substances found in cannabis.
Cannabis Law Report
DECEMBER 25, 2019
Ziad’s presentation focused on their brand introduction, plant history and science, anatomy, terpenes, growing from clone (a leaf trimming) to sale and consumption. All product grown from the female (or feminized) plant, is tested rigorously in compliance with Health Canada’s standards. Generation1.ca Generation1.ca
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MARCH 29, 2020
High product quality relies on a true understanding of the entire supply chain, from seed to sale with sanitized processes and quality checks including the creation of well-detailed preventative control plans that are in place to avoid instances of hazards like contamination or other public safety risks.
Cannabis Law Report
OCTOBER 23, 2019
The new law would recognize recreational (personal, in cannabis clubs or commercial for adult use), scientific and research, medical or pharmaceutic, therapeutic or palliative; and industrial. Following is a preliminary overview of what we consider the main provisions: A. General Purpose. Legalized Uses and Available Licenses. Recreational.
Cannabis Law Report
OCTOBER 17, 2019
As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state.
Expert insights. Personalized for you.
45 
Let's personalize your content